Erika Tsuchiyose
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Erika Tsuchiyose has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Deborah Feifer
Emory University School of Medicine (D.F.), Atlanta, Georgia, USA
3 shared publications - Ijeoma Julie Eche-Ugwu
Phyllis F. Cantor Center for Research in Nursing and Patient Care Services Dana‐Farber Cancer Institute Boston Massachusetts USA
3 shared publications Joanne Wolfe
Harvard Medical School (I.E., O.A., A.R., C.U., J.W.), Boston, Massachusetts, USA; Department of Pediatrics (J.W.), Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Pediatrics (J.W.), Brigham & Women's Hospital, Boston, Massachusetts, USA
3 shared publications- Maria Laura Requena
Pediatric Palliative Care Innovation, Discovery, Evaluation, and Advancement Lab (PPC IDEA Lab) (J.M.S., M.L.R., M.E.A., V.D., J.W.), Mass General Brigham for Children, Boston, Massachusetts; Center for Research and Implementation in Palliative Care (M.L.R.), Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina
3 shared publications - Veronica Dussel
Pediatric Palliative Care Research, Massachusetts General Hospital Boston Massachusetts USA
3 shared publications - Alexandra Merz
Washington University School of Medicine in St. Louis, MO
2 shared publications
Latest Publications
- 1 September 2025
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 70 (6) , 649-663
Research Burden in Pediatric Cancer: A Mixed Methods Study From the PediQUEST Response Trial
- 1 September 2025
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 70 (6) , 649-663
Research Burden in Pediatric Cancer: A Mixed Methods Study From the PediQUEST Response Trial
- Open Access
- 1 August 2025
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 12 (8) , e01815
Endonephrology: Evolving Techniques of Endoscopic Ultrasound in Diagnosing Renal Lymphoma
Mucosa-associated lymphoid tissue lymphoma is a subtype of non-Hodgkin lymphoma, exceedingly rare when originating in the kidney. Most renal masses are percutaneously sampled with ultrasound or computed tomography guidance; however, limitations can include location, size, and body habitus, which may be resolved using endoscopic ultrasound–guided approaches. We present an unusual case of a 77-year-old man with history of systemic lupus erythematosus, duodenal mucosa–associated lymphoid tissue lymphoma in remission, and rectal adenocarcinoma who presented for evaluation of a right renal mass, which highlights the novelty of endoscopic ultrasound–guided renal evaluation and tissue acquisition.
- 1 August 2025
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 12 (8) , e01815
Open AccessEndonephrology: Evolving Techniques of Endoscopic Ultrasound in Diagnosing Renal Lymphoma
Mucosa-associated lymphoid tissue lymphoma is a subtype of non-Hodgkin lymphoma, exceedingly rare when originating in the kidney. Most renal masses are percutaneously sampled with ultrasound or computed tomography guidance; however, limitations can include location, size, and body habitus, which may be resolved using endoscopic ultrasound–guided approaches. We present an unusual case of a 77-year-old man with history of systemic lupus erythematosus, duodenal mucosa–associated lymphoid tissue lymphoma in remission, and rectal adenocarcinoma who presented for evaluation of a right renal mass, which highlights the novelty of endoscopic ultrasound–guided renal evaluation and tissue acquisition.
- Open Access
- 9 June 2025
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 9 (7)
Culturally tailored steatotic liver disease management: Latino and Asian community partner perspectives and recommendations
Background: Lifestyle modification is the mainstay of treatment for steatotic liver disease (SLD), and recommendations for behavior change require cultural tailoring to enhance their relevance for minority populations. This study aimed to explore community partner perspectives on barriers and facilitators to lifestyle modification and identify ways to improve cultural sensitivity for SLD management. Methods: We conducted semi-structured interviews with 20 community partners (public health professionals, community leaders, and health care workers) from Latino (n=9) and Asian (n=11) communities in San Francisco. Interviews explored community knowledge of SLD, perceived barriers and facilitators to lifestyle changes, and feedback on current education materials. Data were analyzed using thematic analysis. Results: Across 4 levels of influence (societal, community, interpersonal, and individual), 9 shared barriers and 6 shared facilitators emerged. Barriers included poverty, misinformation, social influences, time constraints, and limited nutrition and SLD knowledge, while facilitators included free outdoor spaces, food assistance programs, healthy cultural habits, and family. The Asian community uniquely cited safety concerns for outdoor activities and preference for Eastern medicine, while the Latino community expressed childcare constraints as barriers. We gathered 9 recommendations to improve the cultural sensitivity of lifestyle modification guidance, including working within traditional dietary frameworks, adapting exercise to activities of daily life, and embracing harm reduction for alcohol cessation. Conclusions: Culturally tailored interventions may improve the relevance and sustainability of SLD lifestyle modification recommendations in Latino and Asian communities. Recommendations for interventions include harnessing community-based support, embracing cultural dietary modifications, and promoting feasible physical activity to enhance engagement in these populations. Export
- 9 June 2025
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 9 (7)
Open AccessCulturally tailored steatotic liver disease management: Latino and Asian community partner perspectives and recommendations
Background: Lifestyle modification is the mainstay of treatment for steatotic liver disease (SLD), and recommendations for behavior change require cultural tailoring to enhance their relevance for minority populations. This study aimed to explore community partner perspectives on barriers and facilitators to lifestyle modification and identify ways to improve cultural sensitivity for SLD management. Methods: We conducted semi-structured interviews with 20 community partners (public health professionals, community leaders, and health care workers) from Latino (n=9) and Asian (n=11) communities in San Francisco. Interviews explored community knowledge of SLD, perceived barriers and facilitators to lifestyle changes, and feedback on current education materials. Data were analyzed using thematic analysis. Results: Across 4 levels of influence (societal, community, interpersonal, and individual), 9 shared barriers and 6 shared facilitators emerged. Barriers included poverty, misinformation, social influences, time constraints, and limited nutrition and SLD knowledge, while facilitators included free outdoor spaces, food assistance programs, healthy cultural habits, and family. The Asian community uniquely cited safety concerns for outdoor activities and preference for Eastern medicine, while the Latino community expressed childcare constraints as barriers. We gathered 9 recommendations to improve the cultural sensitivity of lifestyle modification guidance, including working within traditional dietary frameworks, adapting exercise to activities of daily life, and embracing harm reduction for alcohol cessation. Conclusions: Culturally tailored interventions may improve the relevance and sustainability of SLD lifestyle modification recommendations in Latino and Asian communities. Recommendations for interventions include harnessing community-based support, embracing cultural dietary modifications, and promoting feasible physical activity to enhance engagement in these populations. Export
- Open Access
- 14 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E58-E59
Novel hemostatic gel and powder as rescue agents for arterial bleeding related to lumen-apposing metal stent placement
Intraprocedural bleeding following endoscopic ultrasound (EUS)-guided placement of lumen-apposing metal stents (LAMSs) is not an infrequent complication. Significant arterial bleeding may require interventions such as coil embolization or surgical intervention [1]. Identifying and accessing the bleeding site can be particularly challenging when it is obscured by the stent. Recent advances in topical hemostatic agents, such as gels and powders, offer the benefits of broad targeted therapy [2]. We report a unique case detailing the successful management of active arterial bleeding from the gastroepiploic artery after balloon dilation of a LAMS using topical hemostatic gel and powder ([Video 1]). A 39-year-old man with a history of necrotizing pancreatitis and walled-off pancreatic necrotic collections presented with abdominal pain and recurrent walled-off pancreatic necrosis. A computed tomography (CT) angiogram revealed no evidence of a pseudoaneurysm. Under EUS guidance, the stomach wall and the cyst were punctured using an electrocautery-equipped LAMS stent (AXIOS; Boston Scientific, Marlborough, Massachusetts, USA) ([Fig. 1]). A significant arterial bleed occurred from beneath the stent during dilation ([Fig. 2]). Hemostasis was achieved using topical hemostatic gel (PuraStat; 3-D Matrix Europe SAS, Caluire-et-Cuire, France) and powder (EndoClot Plus, Inc., Santa Clara, California, USA) ([Fig. 3], [Fig. 4], [Fig. 5]). The post-procedure CT angiogram showed no active bleeding, and the culprit was identified as the gastroepiploic artery. The patient remained stable and was discharged without requiring additional intervention. Topical hemostatic agents achieve hemostasis by forming mechanical barriers that enhance clot formation [3]. Hemostatic gel, in particular, maintains visibility and has a lower rebleeding rate [4]. While these agents are approved by the U.S. Food and Drug Administration for venous bleeding, their efficacy in managing arterial bleeding remains uncertain [5]. This case demonstrates the evolving role of topical hemostatic agents in managing complex bleeding situations where traditional methods are impractical. Further studies are warranted to refine management strategies and evaluate the long-term outcomes. Endoscopy_UCTN_Code_CPL_1AL_2AD Article published online: 23 January 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 14 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E58-E59
Open AccessNovel hemostatic gel and powder as rescue agents for arterial bleeding related to lumen-apposing metal stent placement
Intraprocedural bleeding following endoscopic ultrasound (EUS)-guided placement of lumen-apposing metal stents (LAMSs) is not an infrequent complication. Significant arterial bleeding may require interventions such as coil embolization or surgical intervention [1]. Identifying and accessing the bleeding site can be particularly challenging when it is obscured by the stent. Recent advances in topical hemostatic agents, such as gels and powders, offer the benefits of broad targeted therapy [2]. We report a unique case detailing the successful management of active arterial bleeding from the gastroepiploic artery after balloon dilation of a LAMS using topical hemostatic gel and powder ([Video 1]). A 39-year-old man with a history of necrotizing pancreatitis and walled-off pancreatic necrotic collections presented with abdominal pain and recurrent walled-off pancreatic necrosis. A computed tomography (CT) angiogram revealed no evidence of a pseudoaneurysm. Under EUS guidance, the stomach wall and the cyst were punctured using an electrocautery-equipped LAMS stent (AXIOS; Boston Scientific, Marlborough, Massachusetts, USA) ([Fig. 1]). A significant arterial bleed occurred from beneath the stent during dilation ([Fig. 2]). Hemostasis was achieved using topical hemostatic gel (PuraStat; 3-D Matrix Europe SAS, Caluire-et-Cuire, France) and powder (EndoClot Plus, Inc., Santa Clara, California, USA) ([Fig. 3], [Fig. 4], [Fig. 5]). The post-procedure CT angiogram showed no active bleeding, and the culprit was identified as the gastroepiploic artery. The patient remained stable and was discharged without requiring additional intervention. Topical hemostatic agents achieve hemostasis by forming mechanical barriers that enhance clot formation [3]. Hemostatic gel, in particular, maintains visibility and has a lower rebleeding rate [4]. While these agents are approved by the U.S. Food and Drug Administration for venous bleeding, their efficacy in managing arterial bleeding remains uncertain [5]. This case demonstrates the evolving role of topical hemostatic agents in managing complex bleeding situations where traditional methods are impractical. Further studies are warranted to refine management strategies and evaluate the long-term outcomes. Endoscopy_UCTN_Code_CPL_1AL_2AD Article published online: 23 January 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- Open Access
- 1 December 2024
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 11 (12) , e01566
Endoscopic Ultrasound-Guided Diagnosis of Gallbladder Mixed Neuroendocrine Non-Neuroendocrine Tumor With an Anomalous Pancreaticobiliary Junction
Mixed neuroendocrine non-neuroendocrine neoplasms are exceedingly rare tumors, especially those of gallbladder origin. Anomalous pancreaticobiliary junction is an uncommon congenital abnormality that can predispose various types of hepatobiliary malignancies. We present an unusual case of a 46-year-old woman with anomalous pancreaticobiliary junction who presented to the emergency department with nausea, vomiting, and right upper quadrant pain. Magnetic resonance imaging revealed a gallbladder mass concerning for primary malignancy and liver lesions. Endoscopic ultrasound and fine-needle biopsy were valuable diagnostic tools used to sample the gallbladder, liver lesions, and common hepatic duct under one minimally invasive procedure. Pathology showed a gallbladder mixed neuroendocrine non-neuroendocrine neoplasms, with neuroendocrine components in the liver and adenocarcinoma components in the common hepatic duct.
- 1 December 2024
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 11 (12) , e01566
Open AccessEndoscopic Ultrasound-Guided Diagnosis of Gallbladder Mixed Neuroendocrine Non-Neuroendocrine Tumor With an Anomalous Pancreaticobiliary Junction
Mixed neuroendocrine non-neuroendocrine neoplasms are exceedingly rare tumors, especially those of gallbladder origin. Anomalous pancreaticobiliary junction is an uncommon congenital abnormality that can predispose various types of hepatobiliary malignancies. We present an unusual case of a 46-year-old woman with anomalous pancreaticobiliary junction who presented to the emergency department with nausea, vomiting, and right upper quadrant pain. Magnetic resonance imaging revealed a gallbladder mass concerning for primary malignancy and liver lesions. Endoscopic ultrasound and fine-needle biopsy were valuable diagnostic tools used to sample the gallbladder, liver lesions, and common hepatic duct under one minimally invasive procedure. Pathology showed a gallbladder mixed neuroendocrine non-neuroendocrine neoplasms, with neuroendocrine components in the liver and adenocarcinoma components in the common hepatic duct.
- 15 October 2024
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 69 (2) , e131-e138
Parent Views on Parent and Child-reported Outcomes in Pediatric Advanced Cancer: A Qualitative Study
- 15 October 2024
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 69 (2) , e131-e138
Parent Views on Parent and Child-reported Outcomes in Pediatric Advanced Cancer: A Qualitative Study
- 6 June 2023
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 66 (3) , e327-e334
Patient-Reported Outcome Benefits for Children with Advanced Cancer and Parents: A Qualitative Study
- 6 June 2023
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 66 (3) , e327-e334
Patient-Reported Outcome Benefits for Children with Advanced Cancer and Parents: A Qualitative Study